Actively Recruiting
RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention
Led by RAK Medical and Health Sciences University · Updated on 2025-03-12
479
Participants Needed
1
Research Sites
48 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to determine if a pharmacist-led educational intervention can reduce the inappropriate use of proton pump inhibitors (PPIs) among adult patients (≥18 years) with potentially inappropriate PPI prescriptions in Ras Al Khaimah. The main questions it aims to answer are: * Can a pharmacist-led education program reduce unnecessary PPI use? * Does the intervention improve patients' quality of life and reduce healthcare costs? Researchers will compare the intervention group (receiving pharmacist-led education and materials) to the usual care group to see if the intervention reduces PPI use and improves patient outcomes. Participants will: * Receive educational materials from pharmacists, including a patient educational brochure, PPI patient decision aid, PPI deprescribing pamphlet, and PPI patient action plan. * Physicians involved will also receive a pharmaceutical intervention, which includes a physician educational brochure, PPI evidence-based deprescribing guideline, PPI deprescribing algorithm, and whiteboard videos on PPI deprescribing. * Patients will be followed up for 6 months to monitor changes in PPI use, symptoms, and quality of life.
CONDITIONS
Official Title
RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Physicians prescribing PPIs in outpatient departments of the study sites
- Physicians have patients with potentially inappropriate PPI prescriptions
- Patients aged 18 years or older
- Patients presenting to outpatient departments of the study sites
- Patients have potentially inappropriate PPI prescriptions
- Patients' treating physicians are included in the study
You will not qualify if you...
- Physicians involved in any other prescribing trial
- Patients unable to give informed consent as judged by their physicians
- Patients with definitive indications for PPI use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ibrahim Bin Hamad Obaidullah Hospital
Ras al-Khaimah, United Arab Emirates
Actively Recruiting
Research Team
S
Syed Arman Rabbani
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here